Manufacturer Abbott says it could soon produce 50 million of the tests per month.
The Food and Drug Administration has authorized emergency use of a coronavirus test that costs $5 and can produce results in 15 minutes without the use of any lab equipment.
Health care providers still must administer the test but it can be done in point-of-care settings like offices. Data that Abbott submitted to the FDA show that the test accurately detects 97.1 percent of positive samples and 98.5 percent of negative samples. “It’s exciting to see something come on the market that’s fast, easy to use, can be made by the millions and is inexpensive,” said Scott Becker, CEO of the Association of Public Health Laboratories.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Abbott wins U.S. authorization for $5 rapid Covid-19 antigenAbbott Laboratories said on Wednesday it won U.S. marketing authorization for a Covid-19 portable antigen test that can deliver results within 15 minutes and will sell for $5.
Read more »
Abbott’s $5 Covid-19 Rapid Antigen Test Gets Emergency-Use Status From FDAThe Food and Drug Administration has granted emergency-use authorization to Abbott Laboratories for a $5 rapid-response Covid-19 antigen test that is roughly the size of a credit card.
Read more »
You may receive a check for $5 or less from US Treasury — and here's whySome unusual interest payments are being made in late August by the U.S. Treasury. Here's why and how to know if your check is real.
Read more »
8 Throw-Together Meals from Whole Foods for Under $5Whole Foods is notoriously touted as expensive and inaccessible. With a little due diligence, one dietician was able to scout out some meals at Whole Foods that give Trader Joe’s a run for its money. Each of these gems is less than $5 per serving.
Read more »
After Dow inclusion news, Salesforce stock soars on reveal of first $5 billion quarterA day after Salesforce.com Inc. was announced as the first cloud-software entry into the Dow Jones Industrial Average, the San Francisco company announced...
Read more »
FDA chief issues mea culpa for his plasma treatment claimsFDA Commissioner Stephen Hahn issued a mea culpa late yesterday, conceding that he had overstated the benefits of convalescent plasma as a treatment of coronavirus at a press conference last weekend with President Trump
Read more »